In this perspective, the mTOR pathway and TSC genes are thought to be affected by epigenetic modifications, and growing evidence suggests that these alterations may contribute to the regulation of gene expression and the diverse clinical features observed in tuberous sclerosis complex [22]. The gene discussed is TSC1; the disease is tuberous sclerosis.